Effects of TGMXD-208, a Novel PI3K Inhibitor, on Adjuvant-induced Arthritic Rats by Suppressing PI3K/AKT Signaling Pathway
TGMXD-208 cuts down arthritic symptoms in AA rats by blocking the PI3K/AKT pathway, making it a potential treatment option for RA.
Authors
- Wenrui Su
- Ran Tang (ORCID: https://orcid.org/0000-0003-3664-2497)
- Xiaodong Ma (ORCID: https://orcid.org/0000-0001-7158-8073)
- Shuangying Gui (ORCID: https://orcid.org/0000-0002-8221-9676)
- Xiaoyi Jia (ORCID: https://orcid.org/0000-0002-3795-4399)
- Jiayu Wang (ORCID: https://orcid.org/0000-0001-5957-4840)
- Jiahua Yin
- Zhifang Qin
Institutions
- Anhui University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-05-22
- DOI
- https://doi.org/10.2174/0118715303373717250509063328
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00